US Stock MarketDetailed Quotes

MBOT Microbot Medical

Watchlist

1.870
-0.960-33.92%

Close Jan 8 16:00 ET

1.900
+0.030+1.60%

Post 20:01 ET

38.62MMarket Cap-2.37P/E (TTM)

Microbot Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-66.71%-2.76M

-5.56%-1.96M

24.45%-2.42M

26.11%-8.53M

26.07%-1.82M

43.99%-1.66M

40.65%-1.85M

-6.52%-3.2M

-23.47%-11.55M

14.69%-2.46M

Net income from continuing operations

-31.44%-3.22M

-7.78%-2.47M

16.89%-2.37M

18.44%-10.74M

-5.20%-3.15M

29.47%-2.45M

34.90%-2.29M

10.54%-2.85M

-16.40%-13.17M

22.31%-3M

Operating gains losses

----

-60.00%2K

----

--5K

----

Depreciation and amortization

15.00%23K

-46.15%14K

12.00%28K

3.92%106K

6.06%35K

-20.00%20K

13.04%26K

19.05%25K

34.21%102K

17.86%33K

Other non cash items

97.14%-2K

----

6,066.67%716K

--821K

---70K

---8K

-2,800.00%-27K

---12K

----

Change In working capital

-69.90%152K

-209.09%-72K

30.26%-530K

95.18%-11K

125.32%178K

1,703.57%505K

200.00%66K

-182.53%-760K

-145.88%-228K

-86.21%79K

-Change in prepaid assets

-125.54%-59K

-2.25%174K

-377.86%-389K

5,069.23%672K

136.50%123K

-23.26%231K

239.06%178K

-20.90%140K

-92.66%13K

-865.91%-337K

-Change in payables and accrued expense

-22.99%211K

90.18%-11K

58.22%-376K

-183.40%-683K

-86.78%55K

200.37%274K

-280.65%-112K

-101.79%-900K

-175.31%-241K

-21.36%416K

-Change in other working capital

----

--235K

----

Cash from discontinued investing activities

Operating cash flow

-66.71%-2.76M

-5.56%-1.96M

24.45%-2.42M

26.11%-8.53M

26.07%-1.82M

43.99%-1.66M

40.65%-1.85M

-6.52%-3.2M

-23.47%-11.55M

14.69%-2.46M

Investing cash flow

Cash flow from continuing investing activities

105.44%140K

191.58%1.19M

-144.54%-1.28M

151.43%1.97M

178.79%2.96M

-51,340.00%-2.57M

-1,988.71%-1.3M

18,118.75%2.88M

-219.88%-3.84M

-227.01%-3.75M

Net PPE purchase and sale

--0

60.00%-4K

---14K

60.71%-33K

400.00%3K

-420.00%-26K

83.87%-10K

--0

-21.74%-84K

97.73%-1K

Net investment purchase and sale

105.50%140K

192.61%1.19M

-144.05%-1.27M

153.46%2.01M

178.73%2.95M

---2.55M

---1.29M

--2.88M

-214.78%-3.75M

-225.11%-3.75M

Cash from discontinued investing activities

Investing cash flow

105.44%140K

191.58%1.19M

-144.54%-1.28M

151.43%1.97M

178.79%2.96M

-51,340.00%-2.57M

-1,988.71%-1.3M

18,118.75%2.88M

-219.88%-3.84M

-227.01%-3.75M

Financing cash flow

Cash flow from continuing financing activities

493.17%633K

-69.13%2.07M

2.4M

51.67%6.56M

-161K

6.72M

4.32M

Net common stock issuance

493.17%633K

-69.13%2.07M

--2.4M

51.67%6.56M

--0

---161K

--6.72M

--0

--4.32M

Cash from discontinued financing activities

Financing cash flow

493.17%633K

-69.13%2.07M

--2.4M

51.67%6.56M

--0

---161K

--6.72M

--0

--4.32M

Net cash flow

Beginning cash position

-56.44%2.51M

-44.97%1.21M

-0.08%2.52M

-81.45%2.52M

-68.69%1.38M

-21.73%5.77M

-79.17%2.2M

-81.45%2.52M

-31.18%13.58M

-67.35%4.41M

Current changes in cash

54.74%-1.99M

-63.50%1.3M

-308.44%-1.31M

99.98%-2K

160.04%1.14M

-48.24%-4.39M

212.05%3.57M

89.41%-320K

-79.74%-11.06M

-2,882.35%-1.89M

End cash Position

-61.84%527K

-56.44%2.51M

-44.97%1.21M

-0.08%2.52M

-68.69%1.38M

-21.73%5.77M

-79.17%2.2M

-81.45%2.52M

Free cash flow

-63.93%-2.76M

-5.20%-1.96M

24.01%-2.43M

26.36%-8.57M

26.30%-1.82M

43.14%-1.68M

41.49%-1.86M

-5.95%-3.2M

-23.45%-11.63M

15.93%-2.46M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-66.71%-2.76M	-5.56%-1.96M	24.45%-2.42M	26.11%-8.53M	26.07%-1.82M	43.99%-1.66M	40.65%-1.85M	-6.52%-3.2M	-23.47%-11.55M	14.69%-2.46M
Net income from continuing operations	-31.44%-3.22M	-7.78%-2.47M	16.89%-2.37M	18.44%-10.74M	-5.20%-3.15M	29.47%-2.45M	34.90%-2.29M	10.54%-2.85M	-16.40%-13.17M	22.31%-3M
Operating gains losses	----	----	----	-60.00%2K	----	----	----	----	--5K	----
Depreciation and amortization	15.00%23K	-46.15%14K	12.00%28K	3.92%106K	6.06%35K	-20.00%20K	13.04%26K	19.05%25K	34.21%102K	17.86%33K
Other non cash items	97.14%-2K	----	----	6,066.67%716K	--821K	---70K	---8K	-2,800.00%-27K	---12K	----
Change In working capital	-69.90%152K	-209.09%-72K	30.26%-530K	95.18%-11K	125.32%178K	1,703.57%505K	200.00%66K	-182.53%-760K	-145.88%-228K	-86.21%79K
-Change in prepaid assets	-125.54%-59K	-2.25%174K	-377.86%-389K	5,069.23%672K	136.50%123K	-23.26%231K	239.06%178K	-20.90%140K	-92.66%13K	-865.91%-337K
-Change in payables and accrued expense	-22.99%211K	90.18%-11K	58.22%-376K	-183.40%-683K	-86.78%55K	200.37%274K	-280.65%-112K	-101.79%-900K	-175.31%-241K	-21.36%416K
-Change in other working capital	----	----	--235K	----	----	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	-66.71%-2.76M	-5.56%-1.96M	24.45%-2.42M	26.11%-8.53M	26.07%-1.82M	43.99%-1.66M	40.65%-1.85M	-6.52%-3.2M	-23.47%-11.55M	14.69%-2.46M
Investing cash flow
Cash flow from continuing investing activities	105.44%140K	191.58%1.19M	-144.54%-1.28M	151.43%1.97M	178.79%2.96M	-51,340.00%-2.57M	-1,988.71%-1.3M	18,118.75%2.88M	-219.88%-3.84M	-227.01%-3.75M
Net PPE purchase and sale	--0	60.00%-4K	---14K	60.71%-33K	400.00%3K	-420.00%-26K	83.87%-10K	--0	-21.74%-84K	97.73%-1K
Net investment purchase and sale	105.50%140K	192.61%1.19M	-144.05%-1.27M	153.46%2.01M	178.73%2.95M	---2.55M	---1.29M	--2.88M	-214.78%-3.75M	-225.11%-3.75M
Cash from discontinued investing activities
Investing cash flow	105.44%140K	191.58%1.19M	-144.54%-1.28M	151.43%1.97M	178.79%2.96M	-51,340.00%-2.57M	-1,988.71%-1.3M	18,118.75%2.88M	-219.88%-3.84M	-227.01%-3.75M
Financing cash flow
Cash flow from continuing financing activities	493.17%633K	-69.13%2.07M	2.4M	51.67%6.56M	0	-161K	6.72M	0	4.32M	4.32M
Net common stock issuance	493.17%633K	-69.13%2.07M	--2.4M	51.67%6.56M	--0	---161K	--6.72M	--0	--4.32M	--4.32M
Cash from discontinued financing activities
Financing cash flow	493.17%633K	-69.13%2.07M	--2.4M	51.67%6.56M	--0	---161K	--6.72M	--0	--4.32M	--4.32M
Net cash flow
Beginning cash position	-56.44%2.51M	-44.97%1.21M	-0.08%2.52M	-81.45%2.52M	-68.69%1.38M	-21.73%5.77M	-79.17%2.2M	-81.45%2.52M	-31.18%13.58M	-67.35%4.41M
Current changes in cash	54.74%-1.99M	-63.50%1.3M	-308.44%-1.31M	99.98%-2K	160.04%1.14M	-48.24%-4.39M	212.05%3.57M	89.41%-320K	-79.74%-11.06M	-2,882.35%-1.89M
End cash Position	-61.84%527K	-56.44%2.51M	-44.97%1.21M	-0.08%2.52M	-0.08%2.52M	-68.69%1.38M	-21.73%5.77M	-79.17%2.2M	-81.45%2.52M	-81.45%2.52M
Free cash flow	-63.93%-2.76M	-5.20%-1.96M	24.01%-2.43M	26.36%-8.57M	26.30%-1.82M	43.14%-1.68M	41.49%-1.86M	-5.95%-3.2M	-23.45%-11.63M	15.93%-2.46M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Heat List

Overall

No Data